CME: The Latest in the Diagnosis and Management of Nocturnal Polyuria (Nocturia)

Dean Elterman, MD, FRCSC, Assistant Professor, University of Toronto, Toronto Western Hospital, Toronto, ON.

Colin M. Shapiro, MBBCh, PhD, MRCPsych, FRCPC, Professor, University of Toronto, Toronto Western Hospital, Toronto, ON.

Roger S. McIntyre, MD, FRCPC, Professor of Psychiatry and Pharmacology, University of Toronto, Executive Director, Brain and Cognition Discovery Foundation (BCDF), Head, Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON.

Jeremy Gilbert, MD, FRCPC, Assistant Professor, University of Toronto, Endocrinologist, Sunnybrook Health Sciences Centre, Toronto, ON.

This learning program has been developed for primary care physicians, educators, and other health care professionals.

  • It’s best viewed with accompanying video and voice-over narration.
  • This program runs in a sequence, and is accompanied by pre- and post-test quizzes, as well as informative illustrations and animations You may pause, rewind, or fast-forward at any point.
  • Slides with animations will pause automatically; to view the animation press Play on the video itself; to continue to the next slide press Next on the slides viewer controls.
  • After completing this program, at the end of the presentation from the Appendix page, you will be offered to download the “Certificate of Participation.”

After participating in this online CME program, physicians should be able to:
  • To define the clinical condition of nocturia and differentiate it from similar conditions, such as nocturnal polyuria, overactive bladder
  • To understand the impact nocturia has on restorative sleep and subsequent daytime symptoms
  • To learn about management options to treat nocturia, including behavioural and pharmacologic
  • To learn how to screen patients with nocturia for mental health conditions such as major depression
  • To understand how treating nocturia may improve symptoms of hyperglycemia in patients with type 2 diabetes mellitus

This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 2 Mainpro+ credits.
Views and opinions in this program are of the faculty and not necessarily endorsed by, or reflective of, those of the publisher or editors of Health Plexus.

The development of this CME program was supported by an unrestricted educational grant from Ferring Inc.


Very good presentation, however would like to know if we should treat polyuria with DDAVP first instead of prescribing drugs for OAB?

If patient has demonstrated nocturnal polyuria (proven on voiding diary – frequency volume), then DDAVP is more appropriate that an OAB medication.

It was rather difficult to quite understand the association/correlation between Nocturia and Psychiatric conditions.

Excellent comprehensive presentation. I loved the style of each of the presenters. Well done and thank you.

Useful re desmopressin use

The double negative in this question does make it more challenging to understand. Would avoid if possible. I believe examination questions in medical school are no longer allowed to be formatted like this.

can we control nocturia by intensive control of diabetes in DM2 patients ?

Tight control of glucose in diabetics will improve Nocturia if the cause is glucosuria. In other words, if the cause is doing diabetes, the improving it will help, being mindful that there are many causes of Nocturia.